4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-045283
Chief Scientific Officer acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kastelein Johannes Jacob Pieter Chief Scientific Officer | 2025-03-24 | Option exercise | +150,000 | 150,000 | I | ||
| Derivatives | |||||||
| Kastelein Johannes Jacob Pieter Chief Scientific Officer | 2025-03-24 | Option exercise · Option (right to buy) | −150,000 | 820,229 | I | ||
Loading xslF345X05/ownership.xml…